首页 | 本学科首页   官方微博 | 高级检索  
   检索      

磁共振靶向对比剂在淋巴结成像中的研究进展
引用本文:解骞,梁宗辉.磁共振靶向对比剂在淋巴结成像中的研究进展[J].上海生物医学工程,2011(4):206-209.
作者姓名:解骞  梁宗辉
作者单位:[1]复旦大学附属华山医院放射科,上海200040 [2]上海市静安区中心医院放射科,上海200041
摘    要:准确评价淋巴结转移与否关系到对肿瘤患者的分期和预后的判断。目前对淋巴结良恶性诊断的主要依据为淋巴结的大小和形态,正常大小的转移性淋巴结很可能被遗漏,增大的淋巴结是良性增生还是恶性转移也很难鉴别。近年来随着MR特异性对比剂,特别是MR靶向淋巴结对比剂的发展,MR淋巴成像(MR Lymphography,MRL)显示了极为诱人的前景。该文主要介绍MR淋巴靶向对比剂的研究进展。

关 键 词:磁共振成像  靶向对比剂  淋巴成像  淋巴结转移

Progress of MR Targeted Contrast Agents in Lymphography
Xie Qian,Liang Zonghui.Progress of MR Targeted Contrast Agents in Lymphography[J].Shanghai Journal of Biomedical Engineering,2011(4):206-209.
Authors:Xie Qian  Liang Zonghui
Institution:1. Department of Radiolog, Huashan Hospital, Fudan University ;2. Department of Radiology, Shanghai Jingan District Centre Hospital )
Abstract:The accurate evaluation of tumor metastases in prognosis in cancer patients. At present, differentiating between lymph nodes is important for tumor staging and malignant and benign lymph nodes still rely only on the size and shape of the lymph nodes. Thus, small metastases in normal size lymph nodes can be missed, and it is difficult to differentiate enlarged nodes (benign hyperplasia versus malignant disease). Recently, with the advancement of the MR specificity contrast agents, especially MR lymphotropic contrast medium, MR lymphography has shown attractive perspective. This summary mainly introduces the progress of MR targeted contrast agents in lymphography.
Keywords:MR_I  targeted contrast agents  lymphography  lymph node metastases
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号